6.70
price down icon1.18%   -0.08
after-market Handel nachbörslich: 6.70
loading
Schlusskurs vom Vortag:
$6.78
Offen:
$6.66
24-Stunden-Volumen:
388.63K
Relative Volume:
0.65
Marktkapitalisierung:
$405.87M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.81M
KGV:
-3.5638
EPS:
-1.88
Netto-Cashflow:
$74.30M
1W Leistung:
-4.15%
1M Leistung:
-26.37%
6M Leistung:
+63.41%
1J Leistung:
+119.67%
1-Tages-Spanne:
Value
$6.50
$6.805
1-Wochen-Bereich:
Value
$6.50
$7.19
52-Wochen-Spanne:
Value
$2.965
$13.60

Omeros Corporation Stock (OMER) Company Profile

Name
Firmenname
Omeros Corporation
Name
Telefon
206-676-5000
Name
Adresse
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Name
Mitarbeiter
202
Name
Twitter
@OmerosCorp
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
OMER's Discussions on Twitter

Vergleichen Sie OMER mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OMER
Omeros Corporation
6.70 405.87M 0 -117.81M 74.30M -1.88
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Omeros Corporation Stock (OMER) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-23 Eingeleitet D. Boral Capital Buy
2024-11-14 Eingeleitet Rodman & Renshaw Buy
2022-12-08 Herabstufung UBS Buy → Neutral
2022-11-08 Herabstufung BofA Securities Neutral → Underperform
2022-06-08 Herabstufung BofA Securities Buy → Neutral
2021-10-08 Herabstufung JP Morgan Neutral → Underweight
2021-10-01 Herabstufung Maxim Group Buy → Hold
2021-10-01 Herabstufung Wedbush Neutral → Underperform
2021-09-27 Eingeleitet JP Morgan Neutral
2021-02-01 Eingeleitet UBS Buy
2020-10-20 Eingeleitet BofA Securities Buy
2020-08-21 Bestätigt H.C. Wainwright Buy
2020-08-14 Bestätigt Maxim Group Buy
2019-05-06 Eingeleitet Cantor Fitzgerald Overweight
2018-07-12 Eingeleitet Seaport Global Securities Buy
2018-03-23 Herabstufung Wedbush Outperform → Neutral
2018-03-05 Herabstufung Needham Buy → Hold
2017-11-08 Eingeleitet H.C. Wainwright Buy
2017-05-11 Herabstufung Cantor Fitzgerald Buy → Neutral
2017-03-17 Bestätigt Maxim Group Buy
2017-03-17 Bestätigt Needham Buy
2016-11-16 Bestätigt Wedbush Outperform
2016-11-10 Bestätigt Needham Buy
2016-08-10 Bestätigt Maxim Group Buy
2016-06-03 Eingeleitet Cantor Fitzgerald Buy
2016-03-02 Bestätigt Needham Buy
2016-02-29 Bestätigt Wedbush Outperform
2015-11-11 Bestätigt Needham Buy
2015-08-18 Bestätigt WBB Securities Strong Buy
2015-08-10 Eingeleitet ROTH Capital Buy
Alle ansehen

Omeros Corporation Aktie (OMER) Neueste Nachrichten

pulisher
08:02 AM

Omeros Co. (NASDAQ:OMER) Position Increased by Alliancebernstein L.P. - Defense World

08:02 AM
pulisher
Apr 20, 2025

Franklin Resources Inc. Makes New Investment in Omeros Co. (NASDAQ:OMER) - Defense World

Apr 20, 2025
pulisher
Apr 15, 2025

Omeros Co. (NASDAQ:OMER) Shares Sold by ExodusPoint Capital Management LP - The AM Reporter

Apr 15, 2025
pulisher
Apr 15, 2025

Vanguard Group Inc. Reduces Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World

Apr 15, 2025
pulisher
Apr 13, 2025

Raymond James Financial Inc. Invests $124,000 in Omeros Co. (NASDAQ:OMER) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

D. Boral Capital Reiterates Buy Rating for Omeros (NASDAQ:OMER) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

Corebridge Financial Inc. Sells 2,100 Shares of Omeros Co. (NASDAQ:OMER) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Omeros' New Leukemia Drug Team Ignites Hope For Cancer FightOmeros (NASDAQ:OMER) - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Omeros Announces the Omeros Oncology Clinical Steering Committee - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Omeros forms steering committee for leukemia treatment By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Omeros announces oncology clinical steering committee to help guide proprietary Oncotox-AML clinical program - marketscreener.com

Apr 10, 2025
pulisher
Apr 10, 2025

Omeros forms steering committee for leukemia treatment - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program - The Joplin Globe

Apr 10, 2025
pulisher
Apr 09, 2025

Omeros (NASDAQ:OMER) Downgraded by StockNews.com to Sell - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases - Yahoo Finance

Apr 08, 2025
pulisher
Apr 08, 2025

Revolutionary T-CAT Platform Takes Aim at $135B Antibiotic Crisis with 99% Kill Rate - Stock Titan

Apr 08, 2025
pulisher
Apr 07, 2025

It makes sense and dollars to buy Omeros Corporation (OMER) stock - Sete News

Apr 07, 2025
pulisher
Apr 06, 2025

(OMER) Technical Data - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 05, 2025

FY2025 EPS Estimates for Omeros Reduced by Cantor Fitzgerald - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Omeros (NASDAQ:OMER) Upgraded to Hold at StockNews.com - The AM Reporter

Apr 03, 2025
pulisher
Apr 02, 2025

Omeros (NASDAQ:OMER) Earns "Buy" Rating from D. Boral Capital - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Omeros Co. (NASDAQ:OMER) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

4,671 Shares in Omeros Co. (NASDAQ:OMER) Acquired by Quantbot Technologies LP - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Omeros (NASDAQ:OMER) Receives “Hold” Rating from Needham & Company LLC - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Omeros Corporation’s Earnings Call Highlights Progress and Challenges - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Omeros Corporation (NASDAQ:OMER) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

Omeros (OMER) Exceeds Q4 EPS Expectations, Reports Cash Decline - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Omeros: Q4 Earnings Snapshot - CT Insider

Apr 01, 2025
pulisher
Apr 01, 2025

Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ... - Yahoo

Apr 01, 2025
pulisher
Apr 01, 2025

Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with Strategic Initiatives - GuruFocus

Apr 01, 2025
pulisher
Mar 31, 2025

Omeros Corporation Reports 2024 Financial Results - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Omeros Q4 2024 sees narrower EPS loss, stock climbs - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Omeros Q4 2024 sees narrower EPS loss, stock climbs By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Omeros beats Q4 earnings estimates, shares rise 5% By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Omeros beats Q4 earnings estimates, shares rise 5% - Investing.com Australia

Mar 31, 2025
pulisher
Mar 31, 2025

OMEROS CORP SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Omeros reports Q4 EPS (54c), consensus (71c) - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

Omeros (OMER) to Release Quarterly Earnings on Monday - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Top Wall Street Forecasters Revamp Omeros Price Expectations Ahead Of Q4 Earnings - Benzinga

Mar 28, 2025
pulisher
Mar 27, 2025

In the Green: Omeros Corporation (OMER) Closes at 8.52, Up/Down -6.99 from Previous Day - DWinneX

Mar 27, 2025
pulisher
Mar 27, 2025

Omeros Corporation (OMER) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle

Mar 27, 2025
pulisher
Mar 27, 2025

Trend Tracker for (OMER) - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 26, 2025

Strong Buy Rating for Omeros Corporation Driven by Promising Narsoplimab Prospects and Strategic Advancements - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025 - Joplin Globe

Mar 26, 2025
pulisher
Mar 26, 2025

Omeros Earnings Preview: Key Metrics to Watch in Q4 and Full Year Report - Stock Titan

Mar 26, 2025

Finanzdaten der Omeros Corporation-Aktie (OMER)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Kapitalisierung:     |  Volumen (24h):